Skip to main content

Table 2 Substrate utilization and metabolite production of single strains in the presence of glycerol or 1,2-propanediol. Strains were grown in anaerobic YCFA supplied with glycerol or 1,2-propanediol (1,2-PD) (both 50 mM) at 37 °C for 24 h. E. eligens did not grow and utilize glycerol and 1,2-PD. n.d. = not determined; n = number of biological replicates. Values are presented as mean ± standard deviation

From: Gut microbial beta-glucuronidase and glycerol/diol dehydratase activity contribute to dietary heterocyclic amine biotransformation

Straina

Substrate

n

Substrate utilization (mM)

Metabolite production (mM)

Formate

Acetate

Propionate

Butyrate

1,3-PD

B. obeum

1,2-PD

4

−17.9 ± 4.3A*

0A

1.5 ± 1.7AB

5.2 ± 0.4A

− 0.2 ± 0.6A

n.d.

glycerol

6

−2.1 ± 1.2a

0a

1.5 ± 1.4a

− 0.6 ± 0.4a

0a

0

E. hallii

1,2-PD

6

−46.6 ± 6.4B

1.0 ± 0.8A

− 1.6 ± 7.8A

19.3 ± 8.0B

4.3 ± 0.7B

n.d.

glycerol

6

− 13.3 ± 3.0b

0.7 ± 1.0b

− 4.6 ± 2.5b

0 ± 0.8a

0 ± 0.8a

1.9 ± 0.7a

F. prausnitzii

1,2-PD

2

− 0.7C

0A

−1.4 A

0C

1.5A

n.d.

glycerol

3

−1.6 ± 0.4c

0.9 ± 1.6a

1.3 ± 0.5a

0.3 ± 0.2a

0.3 ± 0.6a

0 a

F. plautii

1,2-PD

4

−48.1 ± 1.2B

0A

2.2 ± 1.4A

11.6 ± 3.9B

4.1 ± 0.3B

n.d.

glycerol

4

−9.1 ± 3.0c

0a

5.2 ± 0.7c

−0.5 ± 0.4a

4.3 ± 0.5b

1.2 ± 0.7a

I. butyriciproduens

1,2-PD

5

−1.2 ± 2.9C

0A

2.6 ± 2.6A

− 0.1 ± 0.5C

5.4 ± 0.6B

n.d.

glycerol

3

− 0.8 ± 1.4ac

0a

2.5 ± 1.7ac

−0.1 ± 0.1a

5.3 ± 0.5b

3.0 ± 0.1b

L. reuteri

1,2-PD

3

−9.8 ± 4.2C

0A

−1.0 ± 1.1A

0.9 ± 0.5C

0A

n.d.

glycerol

3

−14.4 ± 8.8b

0a

−0.4 ± 1.1a

0a

0a

5.2 ± 0b

R. hominis

1,2-PD

3

0D

0A

0A

0C

0A

n.g.

glycerol

5

−5.9 ± 1.1c

0a

−8.5 ± 1.3d

−0.5 ± 0.2a

7.4 ± 1.6b

0

R. intestinalis

1,2-PD

3

−0.4 ± 0.4C

0A

− 0.4 ± 0.4A

−0.3 ± 0.1C

0.4 ± 0.2A

n.d.

glycerol

3

−1.4 ± 0.6ac

0a

1.3 ± 1.0a

0.4 ± 0.4a

0.4 ± 0.2a

0a

R. gnavus

1,2-PD

3

−18.0 ± 5.1A

1.1 ± 1.9A

2.2 ± 1.4AB

7.9 ± 2.4A

0.2 ± 0.3A

n.d.

glycerol

3

− 1.4 ± 1.2a

0a

0.8 ± 1.4ae

0a

0a

0.2 ± 0.3a

V. dispar

1,2-PD

4

−1.7 ± 2.4D

1.4 ± 1.6A

0 ± 2.3AB

0.6 ± 0.8C

0A

n.d.

glycerol

4

−4.4 ± 1.4ac

6.6 ± 1.2c

−2.4 ± 1.9be

− 0.5 ± 0.5a

−0.2 ± 0.4a

0a

B. fragilis

1,2-PD

4

−1.0 ± 1.4C

0A

−0.1 ± 1.6A

0.3 ± 0.5C

−0.4 ± 0.4A

n.d.

glycerol

3

− 1.0 ± 0.9ac

0a

0 ± 0.5a

0.6 ± 0.6a

0a

0a

C. freundii

1,2-PD

3

−1.4 ± 1.8D

5.4 ± 0.6B

7.2 ± 1.2B

1.5 ± 0.6D

0A

n.d.

glycerol

3

−2.1 ± 3.2a

6.0 ± 0.5c

5.3 ± 2.0c

−0.8 ± 0.8a

0a

0a

K. pneumoniae

1,2-PD

3

− 42.7 ± 1.1B

5.3 ± 0.1B

3.1 ± 1.5AB

16.7 ± 1.0B

0A

n.d.

glycerol

3

− 48.7 ± 0.8d

17.5 ± 1.2d

10.7 ± 0.2f

0a

0a

16.4 ± 3.3c

  1. *Different letters represent the significant differences (p < 0.05) on the substrate utilization or metabolite production between different strains using multiple comparisons with 2-way ANOVA. Capital letters are for 1,2-PD and the corresponding metabolites, small letters are for glycerol and the corresponding metabolites